Search company, investor...

Predict your next investment

Venture Capital
FINANCE | Investment Firms & Funds
healthcatalystcapital.com

Investments

28

Portfolio Exits

4

Funds

2

About Health Catalyst Capital Management

Health Catalyst Capital Management is an independent private equity fund investing in growth-stage healthcare technology and technology-enabled services businesses that seek to improve the human condition and promote value-based care. Current and former investments include Cardiogram, PierianDx, Medal, Risalto, HealthMine, ReferWell, InsightIn, Artimis, 1DocWay, Board Vitals, Clareto and others.

Headquarters Location

515 Madison Avenue

New York, New York, 10022,

United States

212-752-2225

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest Health Catalyst Capital Management News

Risalto Health collects another $7M for its MSK concierge platform

Nov 14, 2019

After fueling its seed round last year, Health Catalyst Capital Management again lead the startup's funding. Share Musculoskeletal digital health platform Risalto Health bagged $7 million in new funding from Health Catalyst Capital Management, the startup announced yesterday. WHAT THEY DO The New York-based company use artificial intelligence to find muscular and skeletal health providers in the user’s area. Patients navigate these selections through the company’s app, which acts as a digital concierge that helps select prompt, appropriate care for their condition. Risalto aims to partner with payers and providers alike to streamline patients’ access to care. According to the company, the platform has been shown to reduce patients’ pain scores by as much as 50%, and influences members’ care choices at a 95% success rate. Alongside Health Catalyst Capital Management, the company boasts Oxeon Venture Studio as an institutional investor. WHAT IT’S FOR In addition to funding improvements to the platform itself, Risalto said that these new dollars will help scale the digital musculoskeletal program across the nation. "Each day we spend working with patients it becomes more apparent that there is a lack of coordination and vital resources for those with MSK issues," Dr. Daniel Pizzarello, founder and CEO of Risalto, said in a statement. "We're excited to continue our partnership with HCCM to scale nationwide and help ensure that every patient gets the care that they deserve so that they can avoid dangerous drugs and unnecessary surgeries.” MARKET SNAPSHOT Yesterday’s announcement comes nearly a year and a half after Risalto’s $1.5 million seed round , which was also headed by Health Catalyst Capital Management. That same year saw fundings for similar concierge services addressing different areas of care, such as SteadyMD ( $2.5 million in March 2018 ) and Accolade ( $50 million in April 2018 ). Further, it was only two months ago that Firefly announced its $10.2 million Series A round , and the appointment of athenahealth’s former firebrand Jonathan Bush as its executive chairman. ON THE RECORD "Health Catalyst Capital has focused on MSK as a major pain point in the healthcare system. By investing a second time in Risalto Health as it transforms MSK care, Health Catalyst Capital is furthering its mission of improving healthcare system access and quality while lowering costs," Charles Boorady, founding managing director at Health Catalyst Capital Management, said in a statement. “We have been very impressed by the progress made by Dan and the team at Risalto since our last investment. We are excited now to support their scale-up and roll-out to employers and health plans nationally. "  Tags:

Health Catalyst Capital Management Investments

28 Investments

Health Catalyst Capital Management has made 28 investments. Their latest investment was in Vivante Health as part of their Series B on September 9, 2023.

CBI Logo

Health Catalyst Capital Management Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/20/2023

Series B

Vivante Health

$31M

Yes

2

1/31/2023

Series D

Clearsense

$50M

No

3

1/9/2023

Series B

Holmusk

$45M

No

11

6/23/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

12/6/2021

Series A - II

Subscribe to see more

Subscribe to see more

10

Date

9/20/2023

1/31/2023

1/9/2023

6/23/2022

12/6/2021

Round

Series B

Series D

Series B

Series B

Series A - II

Company

Vivante Health

Clearsense

Holmusk

Subscribe to see more

Subscribe to see more

Amount

$31M

$50M

$45M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

3

11

10

10

Health Catalyst Capital Management Portfolio Exits

4 Portfolio Exits

Health Catalyst Capital Management has 4 portfolio exits. Their latest portfolio exit was Simplifeye on April 18, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/18/2023

Acquired

$99M

2

8/31/2022

Acq - Fin

Subscribe to see more

$99M

Subscribe to see more

10

4/12/2022

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

6/18/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/18/2023

8/31/2022

4/12/2022

6/18/2018

Exit

Acquired

Acq - Fin

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

Health Catalyst Capital Management Fund History

2 Fund Histories

Health Catalyst Capital Management has 2 funds, including Health Catalyst Capital II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

6/1/2020

Health Catalyst Capital II

Multi-Stage Venture Capital

Open

$50.75M

3

12/28/2016

Health Catalyst Capital

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

6/1/2020

12/28/2016

Fund

Health Catalyst Capital II

Health Catalyst Capital

Fund Type

Multi-Stage Venture Capital

Subscribe to see more

Status

Open

Subscribe to see more

Amount

$50.75M

$99M

Sources

3

10

Health Catalyst Capital Management Team

2 Team Members

Health Catalyst Capital Management has 2 team members, including current Managing Partner, Charles Boorady.

Name

Work History

Title

Status

Charles Boorady

Managing Partner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Charles Boorady

Subscribe to see more

Work History

Title

Managing Partner

Subscribe to see more

Status

Current

Subscribe to see more

Compare Health Catalyst Capital Management to Competitors

L
Laureate Pharma

Laureate Pharma is a company focused on the healthcare and pharmaceutical industry. It provides a range of services including the synthesis of pharmaceutical substances, the creation of finished dosage forms, and the development and launch of pulmonary drugs. The company primarily sells to the healthcare sector, with a focus on pharmacies and other pharmaceutical companies. It is based in Princeton, New Jersey.

Blaze Systems Logo
Blaze Systems

Blaze Systems is a provider of total LIMS software solutions for the laboratory marketplace.

MedeAnalytics Logo
MedeAnalytics

MedeAnalytics focuses on healthcare data analytics. The company offers solutions to transform complex healthcare data into actionable insights, with a focus on improving value-based care, population health, financial metrics, and patient outcomes. Their main services include providing analytics for revenue cycle management, value-based care, provider network management, and comprehensive dashboards for government Medicare and Medicaid programs. It was founded in 1994 and is based in Richardson, Texas.

K
Kryosphere

Kryosphere provides customized biorepository, logistical, and clinical sample management services to companies with a critical biospecimen component. Kryosphere delivers secure, scalable solutions to customers ranging from small, emerging entities to large corporations worldwide.

Innovaccer Logo
Innovaccer

Innovaccer is a healthcare technology company developing a data activation platform for a patient-centered, connected care delivery continuum. It creates a unified patient record for the healthcare providers and payer-use to enable collaborative care delivery. The company was founded in 2013 and is based in San Francisco, California.

Cedar Gate Technologies Logo
Cedar Gate Technologies

Cedar Gate Technologies is a company that focuses on healthcare technology. The company offers a unified technology and services platform that provides analytics, business intelligence insights, and administrative solutions to improve care delivery. Its primary customers are payers, providers, employers, and administrative services organizations in the healthcare industry. It was founded in 2014 and is based in Greenwich, Connecticut.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.